About this trial
This is a pilot study in 10 men to test the hypothesis that perturbations in substrate flux and the circulating metabolic and pro-inflammatory milieus during a high-fat diet paradigm will modulate DNA methylation of genes in sperm associated with obesity and cardiometabolic dysfunction.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Male based on biological sex
Age 20-35 years
BMI between 18.5 and 24.9 kg/m2
White/Caucasian
Disqualifiers
Unstable weight in the last 3 months (±5% weight loss or gain)
Shift work or working in a factory setting
Habitual smoking or use of tobacco products, including vaping, within the past 6 months.
History of clinically diagnosed diabetes
Trial population
This study will enroll healthy men from the greater Baton Rouge area who meet the above eligibility criteria and are willing to participate in this research trial.
Trial design
Case-crossover
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Sperm DNA methylation
Incidence of DNA methylation (whole genome/epigenome wide) of genes in sperm measured using bisulphate sequencing
Secondary outcomes
Sperm DNA Damage
Comet Assay to determine DNA fragmentation in sperm.
Other outcomes
Metabolic Flexibility (indirect)
Change in respiratory quotient (RQ) from a fasted to a fed state using a metabolic chamber.
Metabolic Flexibility (direct)
Changes to circulating glucose from a fasted (0 minutes) to a fed state (240 minutes).
Continuous glucose monitoring
Mean Amplitude of Glycemic Excursions (MAGE) in response to healthy and high fat diets.
Insulin sensitivity
Mean 24hr glucose and total 24hr c-peptide excretion
Sponsors and contacts
Click on the lead sponsor to view all of their trials.